Ponce, Ricky M.

HRN: 21-75-94  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/06/2026
CEFTAZIDIME 1GM (VIAL)
04/06/2026
04/13/2026
IV
2g
Q8h
CAP-MR
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: